Helixmith Co Ltd
KOSDAQ:084990
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
H
|
Helixmith Co Ltd
KOSDAQ:084990
|
KR |
|
Obrascon Huarte Lain SA
F:HUA
|
ES |
|
N
|
NICE Holdings Co Ltd
KRX:034310
|
KR |
|
B
|
Beneficient
NASDAQ:BENF
|
US |
|
Mapfre SA
MAD:MAP
|
ES |
|
O
|
Obrascon Huarte Lain SA
XMUN:HUA
|
ES |
Intrinsic Value
Is Helixmith Co Ltd undervalued or overvalued?
See the intrinsic value estimate for Helixmith Co Ltd and find out whether today’s valuation is cheap or expensive by its own historical standards.
Do our valuations actually work? See backtest results .
Helixmith Co Ltd looks overvalued.
But is it expensive by its own standards?
See how today’s valuation compares with Helixmith Co Ltd’s past valuations and how the stock performed after similar periods.
Fundamental Analysis
What Helixmith Does
Helixmith is a South Korean biopharmaceutical company that develops medicines based on gene therapy and other drug platforms. Its best-known work is around treatments for nerve damage and pain-related disorders, where it tries to make a patient’s own cells produce therapeutic proteins instead of relying only on repeated drug dosing. The company also works on other biotech drug candidates and related life-science development projects.
- Headquarters
- Korea KR
- IPO date
- Dec 29, 2005
Revenue & Expenses Breakdown
Helixmith Co Ltd
Earnings Waterfall
Helixmith Co Ltd
The intrinsic value for Helixmith Co Ltd (084990) under the Base Case is hidden KRW.
Compared with the current market price of 3 905 KRW, the stock appears hidden.